KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Intangibles (2016 - 2025)

Neogenomics' Intangibles history spans 14 years, with the latest figure at $286.5 million for Q4 2025.

  • For Q4 2025, Intangibles fell 15.65% year-over-year to $286.5 million; the TTM value through Dec 2025 reached $286.5 million, down 15.65%, while the annual FY2025 figure was $286.5 million, 15.65% down from the prior year.
  • Intangibles reached $286.5 million in Q4 2025 per NEO's latest filing, down from $294.2 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $471.0 million in Q2 2021 to a low of $118.2 million in Q1 2021.
  • Average Intangibles over 5 years is $366.7 million, with a median of $377.5 million recorded in 2023.
  • Peak YoY movement for Intangibles: skyrocketed 274.37% in 2021, then dropped 15.65% in 2025.
  • A 5-year view of Intangibles shows it stood at $442.3 million in 2021, then decreased by 7.7% to $408.3 million in 2022, then fell by 8.61% to $373.1 million in 2023, then fell by 8.96% to $339.7 million in 2024, then fell by 15.65% to $286.5 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Intangibles are $286.5 million (Q4 2025), $294.2 million (Q3 2025), and $301.8 million (Q2 2025).